| Friday, March 7, 2008 |
|
| 1:00 pm |
|
Welcome & Introduction |
| 1:15 pm |
|
Plenary Speaker
Barry Buckland, PhD – Vice President, Bioprocess R&D,
Merck Research Laboratories
“Development of a Vaccine Effective Against Cervical Cancer”
|
| 2:15 pm |
|
Russ Middaugh, PhD - A. & T. Higuichi Distinguished Professor of Pharmaceutical Chemistry, University of Kansas
- “An Empirical Phase Diagram/High Throughput Screening Approach to the Formulation of Macromolecular-Based Drugs and their Complexes”
|
| 3:00 pm |
|
Break |
| 3:15 pm |
|
Eric Tomlinson, DSc, PhD – President and Chief Executive Officer, Altea Therapeutics
- “Clinical Benefits of Using the PassPort™ Transdermal System for the Delivery of Water-soluble Drugs and Proteins"
|
| 4:00 pm |
|
James K. Drennen, III , PhD –Associate Dean, Research and Graduate Programs, Mylan School of Pharmacy, Duquesne University
"Quality by Design (QbD) and Process Analytical Technology (PAT) for Process Efficiency”
|
| 4:45 pm |
|
Dennis Choi, MD, PhD – Professor, Executive Director of Strategic Neurosciences Initiative and Director of the Comprehensive Neuroscience Center in the Woodruff Health Sciences Center, Emory University
“Drug Development for Nervous System Disorders”
|
| 5:30 pm |
|
Announcement of 2008 Suddath Winner |
| 5:30 pm- 7:00 pm |
|
Poster Session and Reception |
| |
|
|
| Saturday, March 8, 2008 |
| |
| 8:00 am |
|
Continental Breakfast |
| 8:30 am |
|
Plenary Speaker
Dipika Matthias, MBA - Business Development Officer, PATH
“Immunization Delivery in the Developing World: Challenges, Vision, and Considerations"
|
| 9:30 am |
|
Jeroen Medema, MSc – Principal Investigator, Influenza, Solvay Biologics
"Novel Developments in Manufacturing and Delivery of Seasonal and Pandemic Influenza Vaccines" |
| 10:15 am |
|
Break |
| 10:30 am |
|
Jeff Ulmer, PhD, Head of External Research, Novartis Vaccines & Diagnostics
"New Technologies for Improved Vaccines" |
| 11:15 am |
|
David Constable, PhD – Director and Team Leader, EHS Product Stewardship, Corporate Environment, Health and SafetyGlaxoSmithKline
“Using Green Chemistry to Drive Future Pharma Manufacturing"
|
| 12:00 pm |
|
Lunch |
| 1:00 pm |
|
Bruce Weniger, MD, MPH - Chief of Vaccine Technology, Immunization Safety Office, Centers for Disease Control and Prevention
“Past, Present, and Future of Cutaneous Vaccination for Public Health Disease Control and Pandemic Preparedness”
|
| 1:45 pm |
|
Binghe Wang, PhD - Professor, Medicinal Chemistry, Georgia Research Alliance Eminent Scholar in Drug Discovery, Georgia Cancer Coalition Distinguished Cancer Scientist, Georgia State University
“Going after the ‘Sweet Spot’ in Cancer Detection”
|
| 2:30 pm - 3:00 pm |
|
Ending Event |
| |
|
|
Questions?
Please contact Colly Mitchell at (404) 385-7001 or Email |
